Back to Search
Start Over
Variances in Antiviral Memory T-Cell Repertoire of CD45RA- and CD62L-Depleted Lymphocyte Products Reflect the Need of Individual T-Cell Selection Strategies to Reduce the Risk of GvHD while Preserving Antiviral Immunity in Adoptive T-Cell Therapy.
- Source :
-
Transfusion Medicine & Hemotherapy . 2022, Vol. 49 Issue 1, p30-43. 14p. - Publication Year :
- 2022
-
Abstract
- Introduction: Viral infections and reactivations still remain a cause of morbidity and mortality after hematopoietic stem cell transplantation due to immunodeficiency and immunosuppression. Transfer of unmanipulated donor-derived lymphocytes (DLI) represents a promising strategy for improving cellular immunity but carries the risk of graft versus host disease (GvHD). Depleting alloreactive naïve T cells (TN) from DLIs was implemented to reduce the risk of GvHD induction while preserving antiviral memory T-cell activity. Here, we compared two TN depletion strategies via CD45RA and CD62L expression and investigated the presence of antiviral memory T cells against human adenovirus (AdV) and Epstein-Barr virus (EBV) in the depleted fractions in relation to their functional and immunophenotypic characteristics. Methods: T-cell responses against ppEBV_EBNA1, ppEBV_Consensus and ppAdV_Hexon within TN-depleted (CD45RA−/CD62L−) and TN-enriched (CD45RA+/CD62L+) fractions were quantified by interferon-gamma (IFN-γ) ELISpot assay after short- and long-term in vitro stimulation. T-cell frequencies and immunophenotypic composition were assessed in all fractions by flow cytometry. Moreover, alloimmune T-cell responses were evaluated by mixed lymphocyte reaction. Results: According to differences in the phenotype composition, antigen-specific T-cell responses in CD45RA− fraction were up to 2 times higher than those in the CD62L− fraction, with the highest increase (up to 4-fold) observed after 7 days for ppEBV_EBNA1-specific T cells. The CD4+ effector memory T cells (TEM) were mainly responsible for EBV_EBNA1- and AdV_Hexon-specific T-cell responses, whereas the main functionally active T cells against ppEBV_Consensus were CD8+ central memory T cells (TCM) and TEM. Moreover, comparison of both depletion strategies indicated that alloreactivity in CD45RA− was lower than that in CD62L− fraction. Conclusion: Taken together, our results indicate that CD45RA depletion is a more suitable strategy for generating TN-depleted products consisting of memory T cells against ppEBV_EBNA1 and ppAdV_Hexon than CD62L in terms of depletion effectiveness, T-cell functionality and alloreactivity. To maximally exploit the beneficial effects mediated by antiviral memory T cells in TN-depleted products, depletion methods should be selected individually according to phenotype composition and CD4/CD8 antigen restriction. TN-depleted DLIs may improve the clinical outcome in terms of infections, GvHD, and disease relapse if selection of pathogen-specific donor T cells is not available. [ABSTRACT FROM AUTHOR]
- Subjects :
- *IMMUNOLOGIC memory
*T cells
*GRAFT versus host disease
*HEMATOPOIETIC stem cell transplantation
*LYMPHOCYTES
*PSYCHONEUROIMMUNOLOGY
*IN vitro studies
*FLOW cytometry
*STATISTICS
*CELL culture
*CD4 antigen
*PHOSPHATASES
*DNA virus diseases
*MANN Whitney U Test
*IMMUNOASSAY
*BLOOD cells
*CELL adhesion molecules
*DESCRIPTIVE statistics
*RESEARCH funding
*DATA analysis software
*DATA analysis
*PHENOTYPES
*EPSTEIN-Barr virus diseases
*ANTIGENS
*DISEASE risk factors
Subjects
Details
- Language :
- English
- ISSN :
- 16603796
- Volume :
- 49
- Issue :
- 1
- Database :
- Academic Search Index
- Journal :
- Transfusion Medicine & Hemotherapy
- Publication Type :
- Academic Journal
- Accession number :
- 155051271
- Full Text :
- https://doi.org/10.1159/000516284